2BB score and signals
Gain Therapeutics, Inc.’s current 2BB score is 15 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 0 | Very Low |
| Momentum | 50 | Stable |
| Financial strength | 21 | Weak |
| Quality | 40 | Normal |
| Risk | 48 | Moderate |
Gain Therapeutics, Inc. (GANX) Stock Score & Signals
Gain Therapeutics, Inc. (GANX) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 15 out of 100.
Company facts
| Founded | 2017 |
| Employees | 21 |
| 52-week range | $1.51 – $4.34 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2026-11-10 | — | -0.1292 | — | $0.00 |
| 2026-08-10 | — | -0.1448 | — | $0.00 |
| 2026-05-11 | -0.13 | -0.1403 | $0.00 | $0.00 |
| 2026-03-26 | -0.11 | -0.1479 | $0.00 | $0.00 |